Double-Cross-Linked Hyaluronic Acid Nanoparticles with pH/Reduction Dual-Responsive Triggered Release and pH-Modulated Fluorescence for Folate-Receptor-Mediated Targeting Visualized Chemotherapy
Authors:
- 31 March 2016
- journal article
- research article
- Published by American Chemical Society (ACS) in Biomacromolecules
- Vol. 17 (4) , 1496-1505
Abstract
A versatile folate-receptor-mediated targeting tumor theranostics has been designed for pH/reduction dual-responsive controlled anticancer drug release and pH-modulated fluorescent tumor imaging via facile ionic (pH sensitive) and covalent (reduction responsive) double-cross-linking (DCL) of the folic acid (FA) and Rhodamine 6G modified hyaluronic acid (HA) (FA-HA-Rh 6G). After optimizing the morphology and diameter of the resultant nanoparticles (DCL FA-HA-Rh 6G NPs) via modulating the concentration of the ionic and covalent cross-linking agents, the one with Ca and S contents of 1.70 and 2.84 wt % and an average hydrodynamic diameter of 154 nm was chosen as the desired drug delivery system (DDS) for DOX. They not only had high drug loading capacity and drug encapsulation efficiency (716 ± 34 mg/g and 71.6 ± 3.4%) but also possessed perfect triggered release and strong fluorescence intensity in the stimulated tumor microenvironment. The MTT assay and CLSM analysis revealed that the proposed double-cross-linked HA-based DDS had favorable cytocompatibility and folate-receptor-mediated targeting functionality to the HeLa cells and could obviously enhance the anticancer efficiency of DOX. The integration of the pH and reduction dual-responsiveness, folate-receptor-mediated targeting functionality, and pH-dependent fluorescence intensity into the biodegradable and biocompatible HA nanoparticles make the DCL FA-HA-Rh 6G NPs significant potential for future visualized chemotherapy of cancers.Keywords
Funding Information
- Program for New Century Excellent Talents in University (NCET-09-0441)
- Ministry of Education of the People's Republic of China (Z2012116)
- National Natural Science Foundation of China (20904017)
This publication has 52 references indexed in Scilit:
- Targeting strategies for delivery of anti-HIV drugsJournal of Controlled Release, 2014
- The potential use of H102 peptide-loaded dual-functional nanoparticles in the treatment of Alzheimer's diseaseJournal of Controlled Release, 2014
- Bio-Inspired Synthetic Nanovesicles for Glucose-Responsive Release of InsulinBiomacromolecules, 2014
- Amphiphilic dendritic derivatives as nanocarriers for the targeted delivery of antimalarial drugsBiomaterials, 2014
- Breakthrough discoveries in drug delivery technologies: The next 30 yearsJournal of Controlled Release, 2014
- Angiopep‐Conjugated Electro‐Responsive Hydrogel Nanoparticles: Therapeutic Potential for EpilepsyAngewandte Chemie International Edition, 2014
- Self-Assembling Doxorubicin–Tocopherol Succinate Prodrug as a New Drug Delivery System: Synthesis, Characterization, and in Vitro and in Vivo Anticancer ActivityBioconjugate Chemistry, 2013
- Mesoporous silica nanoparticles as antigen carriers and adjuvants for vaccine deliveryNanoscale, 2013
- Supramolecular Nanostructures Formed by Anticancer Drug AssemblyJournal of the American Chemical Society, 2013
- Targeted Chemo-Photothermal Treatments of Rheumatoid Arthritis Using Gold Half-Shell Multifunctional NanoparticlesACS Nano, 2012